METHOD FOR ASSESSING NON-SPECIFIC BODY RESISTANCE IN HIP DISPLASIA IN CHILDREN Russian patent published in 2015 - IPC G01N33/48 G01N33/68 

FIELD: medicine.

SUBSTANCE: clinical examination and diagnosis verification is followed by sampling patient's biological material - venous blood. Blood serum samples are prepared. The blood serum samples are analysed to quantify oligomeric matrix cartilage protein by enzyme linked immunosorbent assay and medium molecular weight peptides by spectrophotometric analysis at wave length 254 nm. If the oligomeric matrix cartilage protein amount is more than 1785 ng/l, whereas the medium molecular weight peptide count is more than 0.38 optical density units, non-specific body resistance is stated.

EFFECT: invention provides the more accurate assessment of non-specific body resistance by using as criteria the parameters reflecting more objectively a child's ability to give a response to external factors and presence of pathology, namely hip dysplasia.

1 ex